Picture of Natco Pharma logo

NATCOPHARM Natco Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

REG - Official List JSC NatCo Kaz.Temir - Removal- JSC Nat Company Kazakhstan Temir Zholy

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221121:nRSU9183Ga&default-theme=true

RNS Number : 9183G  Official List  21 November 2022

 NOTICE OF REMOVAL OF LISTING FROM THE OFFICIAL LIST
 21/11/2022 08:00
 REMOVAL
 JSC National Company Kazakhstan Temir Zholy
 The Financial Conduct Authority ("the FCA") removes the securities set out
 below from the Official List effective from 21/11/2022 08:00:

 

 Security Description                                                          Listing Category  ISIN
 6.950% Notes due 10/07/2042; fully paid; (Registered in denominations of      Standard Debt     XS0799658637 ●
 USD200,000 each and integral multiples of USD1,000 in excess thereof)
 (Regulation S)
 6.950% Notes due 10/07/2042; fully paid; (Registered in denominations of      Standard Debt     US48667DAD66 ●
 USD200,000 each and integral multiples of USD1,000 in excess thereof) (Rule
 144A)

 

This notice has been issued by Issuer Management - 020 7066 8352.

 Notes

SEDOL numbers which are allocated by the London Stock Exchange as a Stock
 Exchange identifier may be found on their dealing notice.

●Denotes the security is being admitted to trading on the London Stock
 Exchange, a Recognised Investment Exchange.

†Denotes the security is also being admitted to trading on Aquis Stock
 Exchange, a Recognised Investment Exchange.

#Denotes the security is also being admitted to trading on Euronext, a
 Recognised Investment Exchange.

 ∼Denotes the security is also being admitted to trading on Cboe Europe, a
 Recognised Investment Exchange.

^Denotes the security is also being admitted to trading on Shanghai-London
 Stock Connect, a Recognised Investment Exchange.

*Denotes the security is also being admitted to trading on IPSX Prime, a
 Recognised Investment Exchange.

Notices issued by the FCA in respect of admission of securities to the
 Official List must be read in conjunction with notices issued by the relevant
 Recognised Investment Exchange in respect of admission of securities to
 trading on its markets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOTBPBLTMTIBMJT

Recent news on Natco Pharma

See all news